Haverford Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Haverford Trust CO

$10.2 Billion
Q3 2024

A detailed history of Haverford Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Haverford Trust CO holds 307 shares of REGN stock, worth $215,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

307

Previous 285 7.72%

Holding current value

$215,695

Previous $299,000 7.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$1024.09 - $1201.76 $22,529 - $26,438	22 Added 7.72%	307 $322,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $4,416 - $5,355	5 Added 1.79%	285 $299,000
Q1 2024 May 02, 2024	SELL	$902.69 - $993.35 $57,772 - $63,574	-64 Reduced 18.6%	280 $269,000
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $16,278 - $18,515	21 Added 6.5%	344 $302,000
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $2,100 - $2,491	3 Added 0.94%	323 $232,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $19,734 - $23,982	29 Added 9.97%	320 $262,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $205,413 - $223,019	291 New	291 $209,000
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $202,935 - $238,164	-341 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $543 - $670	1 Added 0.29%	341 $215,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $34,441 - $40,857	-60 Reduced 15.0%	340 $206,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $83,685 - $98,861	177 Added 79.37%	400 $223,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $105,434 - $124,554	223 New	223 $223,000
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $188,520 - $231,340	-422 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $10,522 - $13,375	22 Added 5.5%	422 $204,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $197,328 - $257,567	400 New	400 $249,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Regeneron Pharmaceuticals, Inc. Transaction History